However, the relationship between blood MCP-1 and the risk of developing AD is not consistent across different studies.(1) We hypothesized that the levels of blood MCP-1 differently impact vulnerable people with AD risk genes, to increase AD risk. This evidence concerns the gene CCL2 and Alzheimer disease.